CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, ...
Cancer Center at Illinois (CCIL) members Ratnakar Singh and Michael Spinella collaborated in new research that fills in ...
When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don ...
As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...
Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By ...
UConn Center on Aging researchers have published a new editorial in the journal Aging titled "Polyploidy-induced senescence: Linking development, differentiation, repair, and (possibly) cancer?" In ...
Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy. In a recent Bioconjugate ...
Cancer Research Institute, New York, NY, USA. The cancer cell therapy landscape continues to evolve rapidly. In 2024, the first approvals of tumour-infiltrating lymphocyte (TIL) and T cell receptor ...
Research has uncovered a surprising biological twist: molecules that help support healthy aging can also contribute to cancer growth.
Researchers at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center uncovered new evidence that extra copies of a ...
While Vir Biotech is best known for its work on infectious diseases, its developing cancer pipeline has delivered a partnership with Astellas that could be worth around $1.4 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results